.
MergerLinks Header Logo

New Deal

New Deal

Announced

Completed

Novo and Bioqube Ventures led an €11m investment in Commit Biologics.

Synopsis

Novo, a life science investor, and Bioqube Ventures, a specialist life sciences investment firm, led an €11m investment in Commit Biologics, a biotech spin-out from Aarhus University.

Principals

Commit Biologics

target

Commit Biologics

Novo Holdings

bidder

Novo Holdings

Show Details & Financials

Market Context

Sort

Kasim Kutay

Kasim Kutay

CEO at NOVO HOLDINGS A/S
Deal Bio
Total Deals
27/
Total Value
£26,731M
Nico Vandervelpen

Nico Vandervelpen

Co-Founder and Managing Partner at BIOQUBE VENTURES
Deal Bio
Total Deals
2/
Total Value
£99M
Niels Bang

Niels Bang

Partner at Gorrissen Federspiel
Deal Bio
Total Deals
26/
Total Value
£10,470M
Nick Stub Laursen

Nick Stub Laursen

CSO and Co-founder at COMMIT BIOLOGICS
Deal Bio
Total Deals
1/
Total Value
£9M
Caroline Boysen

Caroline Boysen

Associate at Gorrissen Federspiel
Deal Bio
Total Deals
12/
Total Value
£5,088M

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required
Register nowSign up with LinkedIn

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US